Her research focuses on the epidemiology of infectious diseases, with particular interest in the evaluation of public health interventions in international populations, including mobile groups who face increased risk due to their changing environmental exposures and limited access to healthcare. She brings over 20+ years of experience working on federal and foundation funded research studies in the US, Latin America, Africa and Asia and has lived abroad in Paraguay, Korea and Bangladesh. She has (co)authored 80+ papers in peer-reviewed journals. Dr. Kelvin’s research includes the design, conduct and analysis of data from numerous randomized control trials (RCT), including evaluations of drug treatment and public health programs, which has helped to inform current policy and treatment recommendations. For example, results from a 2001-2005 RCT in Ecuador she directed helped to establish the efficacy of albendazole as treatment for neurocysticercosis and her three RCTs on HIV self-testing in Kenya were evidence used by the National AIDS & STI Control Programme (NASCOP) at the Kenya Ministry of Health in their decision to make HIV self-testing available in the country. More recently she has worked on evaluating COVID-19 transmission risk and pandemic impact on the health of at-risk populations in the US and abroad.
PhD in Epidemiology from Columbia University, New York, NY
MPhil in Epidemiology from Columbia University, New York, NY
MPH in Epidemiology from Columbia University, New York, NY
MA in Latin American Studies from Tulane University, New Orleans, LA
BA in Psychology from University of Chicago, Chicago, IL
Infectious Disease Epidemiology, HIV/AIDS, Neurocysticercosis, Global Health, randomized controlled trials (RCTs)